| Name: | Bendamustine BEN-2A impurity |
| Catalogue No. | VE005915 |
| CAS No. | N/A |
| Molecular Formula | C19H27Cl2N3O2 |
| Molecular Weight | 400.34 g/mol |
| Status | In-stock |
| IUPAC Name | 4-{5-[Bis-(2-Chloro-ethyl)-amino]-1-methyl-1H- benzoimidazol-2-yl}-butyric acid isopropyl ester |
| Description | Bendamustine BEN-2A impurity (CAS No: N/A) or 4-{5-[Bis-(2-Chloro-ethyl)-amino]-1-methyl-1H- benzoimidazol-2-yl}-butyric acid isopropyl ester is associate impurity of Bendamustine.Bendamustine is used to treat chronic lymphocytic leukemia. Bendamustine is also used to treat indolent B-cell non-Hodgkin lymphoma |
| References | “Sci-Hub | Bendamustine Monotherapy in Advanced and Refractory Chronic Lymphocytic Leukemia | 10.1007/S004320000180.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.1007/s004320000180. |
